A novel and sensitive enzyme immunoassay for neopterin and biopterin using a microtitre plate has been developed. The antiserum against neopterin or biopterin was incubated with samples prepared from human urine or rat tissues, and was placed in a well of microtitre plate, where N 2 -(3-aminopropyl) derivative of neopterin or biopterin was kinked by poly-L-Iysine and glutaraldehyde. The antibody, which did not form the immunocomplex with the hapten in the sample, was bound to the fixed hapten on the plate, and then was measured with anti rabbit IgG and peroxidase anti-peroxidase complex. The detection limits of these pterins were both 0 .1 pmol. The specificity of the assay was so high that this assay system with employing anti-neopterin antiserum completely distinguished neopterin from biopterin, as judged from the cross reactivity (0.002%) and vice versa. The amounts of neopterin and biopterin in human urine and rat tissues measured by the present assay showed a good agreement with those determined by high performance liquid chromatography.
Iutroduction
Neopterin (D-erythro-neopterin) [Fig. 1, 1] and biopterin (L-erythro-biopterin) [Fig. 1, 3] are both biosynthesized from guanosine triphosphate. The concentrations of neopterin and biopterin in urine, serum, or tissues are known to reflect pathological conditions (1 , 2) . (6R)-5,6,7,8-Tetrahydrobiopterin is the cofactor for pteridine-dependent aromatic amino acid monooxygenases, which participate the key steps in the biosynthesis of neurotransmitters such as catecholeamines and indoleamines in the central nerve system (2) . The deficiency of the cofactor has been clearly shown in some neurological disorders like atypical phenylketoneuria (3, 4) and Parkinson's disease (5, 6) .
On the other hand, it has been pointed out that the concentration of neopterin in urine or serum increases in cases of neoplastic diseases (7 -9) , allograft rejection (10) (11) (12) , viral infections including human immunodeficiency virus (13 , 14) . In these diseases when the cellular immunity system is activated, neopterin is released from stimulated macrophages (12, 15) . Therefore, neopterin would be a useful biochemical marker for estimating the activation states of cell medicated immunity and for monitoring those diseases (1, 14) . It might be possible to reduce the transmission of disease including AIDS through blood transfusion by swiftly checking the neopterin concentration of blood donors.
Recently it has been shown that the levels of the two pteridines in amniotic fluid or serum depend on the maturation of fetus (16) or on the aging of adults (17) .
In these studies, it is essential to measure the quantity of the pterins. High performance liquid chromatography is popular for the determination of neopterin and biopterin. However, it is rather time consuming, and cannot be applied for screening of many samples. For this purpose, radioimmunoassay (18 -20) and polarization tluoroimmunoassay (21) have been employed for determining these pterins, but both have some drawback: the former handling a radioactive ligand and the latter having a rather low sensitivity. Therefore, simple and specific assay methods for these pterins are urgently required. In the present paper, we describe a new enzyme immunoassay method for neopterin and biopterin with a high sensitivity and specificity using a specific microtitre plate.
Material and Methods

Specific antisera against neopterin and biopterin
Specific antibodies against neopterin and biopterin were prepared in rabbits using neopterinylcaproyl-or biopterinylcaproyl-bovine serum albumin conjugate, as described previously (18, 19) . These antisera had been lyophilized and stored at -20 cc. Each lyophilized antiserum (original volume, 10 Ill) was dissolved in 20 ml of phosphate buffered saline (PBS) containing 10% normal sheep serum before use.
Other materials
The N 2 -(3-aminopropyl) derivatives of neopterin and biopterin [ Fig. 1, 2 and 4] were synthesized as previously reported (21) . The following pterins were also synthesized in our laboratory according to the following methods: D-ery thro-neopterin and its three stereo isomers (D-threo-, L-erythro-, and L-threo-neopterin) (22) ; L-erythro-biopterin and its stereo isomers (23) .
The microtitre plate with 96 wells was purchased from 
Sample preparations of urine, serum, and tissues for enzyme immunoassay
Urine, serum, and tissue contain neopterin, biopterin , and their dihydro and tetrahydro derivatives (18, 24) . Therefore, the latter two forms were subjected to iodine oxidation before the assay. added to urine (100 Ill). After standing in the dark at room temperature for 1 h, a 1/ 10 volume of 4% ascorbic acid was added and the mixture was lyophilized (18) . The residue was dissolved in a small volume of PBS and was used for the enzyme immunoassay.
A mixture of human serum (2 ml), 2 M trichloroacetic acid (0.5 ml), 5 M hydrochloric acid (0.2 ml), and 2% iodine in 4% potassium iodide (0.2 ml) was kept in the dark at room temperature for 1 h. A solution of 4% ascorbic acid (0.2 ml) was added, and then the mixture was centrifuged at 3000 rpm for 10 min. The supernatant was applied to a cation exchange column (Dowex 50W-X4, 00.5 x 3 cm), and the column was washed with water (10 ml). The pterins were eluted with 2 ml of 1 M ammonia and the eluant was lyophilized. The residue \vas dissolved in PBS (0.1 ml) and an aliquot of this solution was used for immunoassay. Rat liver and kidney (10-200 mg) were homogenized with 0.04-0.8 ml of 0.1 M sodium phosphate buffer (pH 7.5). A 1/ 4 volume of 2 M trichloroacetic acid and a 1/ 10 volume of 2 M hydrochloric acid were added to the homogenate. Tile mixture was submitted to iodine oxidation as above and centrifuged at 3000 rpm for 10 min. The supernatant was treated by a Dowex column in the same manner as above to prepare a sample solution for the enzyme immunoassay.
Determination of creatinine in urine
The concentration of creatinine in urine was determined according to Boutwell (25) . Namely, to urine (20 Ill), water (3.0 ml), 0.04 M picric acid (1.0 ml), and 0.75 M sodium hydroxide (1.0 ml) were added in this order, and the resulting solution was allowed to stand at room temperature for 25 min. The absorbance at 490 nm was measured on a spectrophotometer. A standard curve used to calculate the amount of creatine in urine was determined in the same way as above, where several standard solutions of creatine of known concentrations were employed instead of urine sample.
Binding of hap tens to a micro titre plate
The [1] , biopterin (L-erythro-biopterin( [3] , and the respective N 2 _(3_ aminopropyl) derivatives [2, 4] .
Each well of a microtitre plate was coated with 150 III of aqueous 0 .01 % poly-L-lysine solution at 4°e for 10 h. After rinsed , the well were filled with 10% glutaraldehyde (200 Ill) to react with the fixed poly-L-Iysine for 1 h. Then, N 2 -(3-aminopropyl) derivative of neopterin or biopterin was linked to the well by incubation with a 10 11M solution (100 Ill) for 1 h. After treated with 200 III of 1 % NaBH4 for 1 h, the well was filled with 200 III of 10% normal sheep serum for 1 h to prevent nonspecific binding of antibodies.
The plate can be stored at 4 ue for several weeks without changing its characteristics.
Enzyme immunoassay procedure for neopterin and biopterin
For the assay of neopterin or biopterin, the sample was at first incubated with an appropriate amount of each antiserum prepared as above. The excess antibody, which conjugated with the hapten fixed to the well, was estimated using goat anti rabbit IgG and peroxidase anti-peroxidase complex.
The 2000-fold diluted antiserum (150 Ill) was preincubated with 20 III of the sample or standard solutions in PBS (from 0 to 100 pmol of neopterin or biopterin) for 1 h. A portion (150 Ill) of the resulting mixture was applied into the well and incubated for 1 h. The wells were washed three times with 200 III of PBS containing 0 .05% Tween 20. Then, 150 III of goat anti rabbit IgG diluted 500-fold with PBS was added to each well and allowed to react with the excess antibody fixed on the plate for 1 h. After washed three times, the wells were filled with 150 III of peroxidaseanti peroxidase complex diluted 2000-fold with PBS and incubated for 1 h.
The peroxidase activity was measured as follows: the wells, after washed three times, were filled with 150 III of 0.5% a-phenylenediamine containing 0.4% H 2 0 2 and incubated for 10 min. The reaction was terminated by adding 50 III of 6M H 2 S0 4 , and the absorbance at 490 nm was measured on a Japan Intermed NJ-2000 Immuno Reader.
High performance liquid chromatography
Neopterin and biopterin in the samples were also determined by high performance liquid chromatography (HPLC) by the method of Fukushima and Nixon (24) with a slight modification using a Partisil 10 sex strong cation exchange column (0.4 cm i. d. x 25 cm) and 30 mM ammonium phosphate buffer (pH 3.5) as a mobile phase (1.0 ml/min). The amounts of the pterins were estimated from the fluorescence intensity at 450 nm with excitation at 355 nm.
Results
Standard curve
The standard curves for neopterin and biopterin obtained by the present enzyme immunoassay are shown in Figure 2 . This assay was highly sensitive and the lower limit of measuring each pterin was about 0 .1 pmol (30 pg) per well, whereas the upper limit was about 100 pmol (3 ng) per well.
To gain a high sensitivity, normal sheep serum was used both for masking the plate to suppreSS the background and for diluting the antisera. In a typical experiment, the Bo value, which corresponded to the amount of antibody bound to the fixed hapten after the antiserum was incubated without the free hapten, was 1.76 at 490 nm, whereas the N value (background) was 0.17. 
Specificity
The cross reactivity of various pterins to the antineopterin antiserum and anti-biopterin antiserum were estimated by preparing serial dilutions of the pterins for the immunoassay system. Both the neopterin and biopterin equivalents were read off the standard curve at the 50% binding values. Each value was divided by the amount of pterin originally added in the system and multiplied by 100 to give percentage cross reaction ( Table 1 ). The specificity of the present immunoassay system was high enough to recognize the differences between the stereo isomers including enantiomer ofneopterin and biopterin. Moreover, this system a lmost completely distinguishes the two predominant pterins, i. c. neopterin and biopterin, in biological samples. The total amount of neopterin and biopterin was completely proportional to the amount of human urine used for the assay up to 5 ~I, as shown in Figure  3 . When an aliquot amount of neopterin or biopterin was added into the sample, the recovery was nearly 100% (Fig. 4) . The values of intraassay and interassay on determination of neopterin in human urine were 0.27 ± 0.02 pmol/nmol creatinine (n = 8) and 0.27 ± 0.02 pmol/ nmol creatine (n = 8), respectively.
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Linearity and recovery
Those of biopterin were 0.54 ± 0.03 pmol/nmol creatinine (n = 7) and 0.51 ± 0.05 pmol/nmol creatinine (n = 7), respectively. ;: amount of neopterin or hlopterin (pmol) added to human urine Figure 4 . Recovery studies on the enzyme immunoassay of neopterm (a) and biopterin (b) using human urine. Various amounts of neopterin or biopterin was added to 1 III of human urine, and then the total amount of neopterin or biopterin in the well was measured according to "Materials and Methods. " 
Physiological data
The concentrations of neopterin and biopterin in human urine and serum determined by the present enzyme immunoassay well agreed with the values obtained by HPLC-fluorometry as shown in Table 2 and 3, respectively.
The concentrations of biopterin in rat liver (n = 4) and kidney (n = 4) determined by the present method 
Discussion
The present enzyme immunoassay method using N 2 _ (3-aminopropyl) derivative of neopterin or biopterin as ligand for the fixed phase possesses high sensitivity and determine the amount of these two pterins in biological sample as low as 0.1 pmol /well (approximately 30 pg/ well), same as those obtained from the competitive radioimmunoassay method previously reported (18, 19) . The specificity of the assay is high enough to distinguish neopterin or biopterin from their stereo isomers as judged from the percentage of cross reactivity shown in Table 1 . It should be also noted that the anti-neopterin antiserum distinguishes neopterin from biopterin , which cross reacts only by 0.002%. The anti -biopterin antiserum also distinguishes biopterin from neopterin with 0.002% cross reactivity. Because of the high specificity, the present enzyme immunoassay does not need the separation of neopterin and biopterin in biological samples prior assay; their separation is sometime difficult even by HPLC (19) .
Owing to the above mentioned favorable characteristic, this assay is applicable for the measurement of neopterin and biopterin in biological samples like urine, serum, and tissue as described above. The quantitative analysis of neopterin and biopterin has been performed by various methods. Gas chromatography-mass spectrometry on sililated pterin derivatives (26) seems hardly applicable for the assay of the two pterins in biological samples. Biopterin has been assayed by bioassay using Crithidia fasciculata (27) or by a radioenzymatic assay based on the cofactor activity of the tetrahydro derivative for phenylalanine hydroxylase (28) . Bioassay and radioenzymatic assay are both rather time consuming and are not exclusive to other pterins , especially those having a polyhydroxyalkyl side chain with the same relative configuration as biopterin . HPLC-fluorometry is sensitive and suitable for the analysis of a small number of samples. Radioimmunoassay can analyze many samples simultaneously with a very high sensitivity and specificity. The only, but serious drawback of radioimmunoassay is handling of the radioactive substances.
The present enzyme immunoassay for neopterin and biopterin are easier to handle than other assays. Therefore it should be useful for clinical diagnosis, especially for the assay of neopterin or biopterin in body fluid s from patients with cancers or atypical phenylketoneuria. In this assay system, it is possible to measure 40 samples in duplicate on a micro titre plate including the determination of standard curve. This is a great advantage on a screening test which needs to treat many samples at once.
